摘要
背景:近年来,将无机和蛋白质纳米载体的优点结合起来的杂化蛋白无机纳米粒子(NPs)在组织工程中的应用引起了人们的极大兴趣。摘要目的:对蛋白质(明胶、醇溶蛋白、丝素、…)杂合蛋白的应用进展作一简要综述。等)与无机NPs(磷酸钙NPs,镉量子点,碳纳米管,…))在组织工程方面。结果:讨论了制备蛋白质功能化无机NPs的各种策略。纳米复合膜、电纺纳米纤维支架、纳米结构胶体复合凝胶和纳米复合冻干海绵是再生医学中最常见的蛋白质-无机纳米杂化制剂。结论:蛋白质-无机纳米复合材料可作为骨、软骨组织再生、工程组织成像、抗血栓形成生物材料和抗菌创面敷料等多种生物医学应用的良好平台。
关键词: 杂化纳米粒子,无机纳米粒子,天然聚合物,蛋白质,组织工程,骨再生。
图形摘要
Current Drug Targets
Title:Protein-inorganic Nanohybrids: A Potential Symbiosis in Tissue Engineering
Volume: 19 Issue: 16
关键词: 杂化纳米粒子,无机纳米粒子,天然聚合物,蛋白质,组织工程,骨再生。
摘要: Background: Recently, a great interest has been paid to the development of hybrid proteininorganic nanoparticles (NPs) for tissue engineering applications to combine the merits of both inorganic and protein nanocarriers.
Objective: This short review primarily discusses the most important advances in the application of the hybrids of proteins (gelatin, zein, silk fibroin,….etc) with inorganic NPs (calcium phosphate NPs, cadmium QDs, carbon nanotubes,…etc) in tissue engineering.
Results: Various strategies that have been utilized for the preparation of protein-functionalized inorganic NPs are discussed. Nanocomposite films, electrospun nanofibrous scaffolds, nanostructured colloidal composite gels and nanocomposite lyophilized sponges are among the most common platforms of protein-inorganic nanohybrid formulations used in regenerative medicine.
Conclusion: protein-inorganic nanohybrids could serve as promising platforms for different biomedical applications including bone and cartilage tissue regeneration, imaging of engineered tissues, development of antithrombogenic implant biomaterials and anti-bacterial wound dressing as well.
Export Options
About this article
Cite this article as:
Protein-inorganic Nanohybrids: A Potential Symbiosis in Tissue Engineering, Current Drug Targets 2018; 19 (16) . https://dx.doi.org/10.2174/1389450118666171027111050
DOI https://dx.doi.org/10.2174/1389450118666171027111050 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
MicroRNA-dependent Regulation of Telomere Maintenance Mechanisms: A Field as Much Unexplored as Potentially Promising
Current Pharmaceutical Design Gastrin-Releasing Peptide Receptor Targeting in Cancer Treatment: Emerging Signaling Networks and Therapeutic Applications
Current Drug Targets Targeting Sarcomas: Novel Biological Agents and Future Perspectives
Current Drug Targets Antineoplastic Effects of PPARγ Agonists, with a Special Focus on Thyroid Cancer
Current Medicinal Chemistry Transition Metal-Based Prodrugs for Anticancer Drug Delivery
Current Medicinal Chemistry Pharmacological Approaches to Chronic Spinal Cord Injury
Current Pharmaceutical Design Evaluating Protein-protein Interaction (PPI) Networks for Diseases Pathway, Target Discovery, and Drug-design Using `In silico Pharmacology`
Current Protein & Peptide Science Nutriproteomics – Linking Proteomics Variation with Personalized Nutrition
Current Pharmacogenomics and Personalized Medicine The Role of Mediterranean Diet, CoQ10 and Conjugated-Melatonin in Osteoporosis Primary Prevention and Therapy
Current Nutrition & Food Science Presence of Intratumoral Stem Cells in Breast Cancer Patients with or without BRCA Germline Mutations
Current Cancer Drug Targets Cancer Prevention with Promising Natural Products: Mechanisms of Action and Molecular Targets
Anti-Cancer Agents in Medicinal Chemistry Peptide-Drug Conjugate: A Novel Drug Design Approach
Current Medicinal Chemistry Synthesis and Anticancer Properties of Methyl N1-(thien-4-yl)amidrazone- 3-carboxylates
Letters in Drug Design & Discovery α2-Adrenoceptors Enhance Cell Proliferation and Mammary Tumor Growth Acting Through both the Stroma and the Tumor Cells
Current Cancer Drug Targets Tyrosine Kinase Inhibitors Gefitinib, Lapatinib and Sorafenib Induce Rapid Functional Alterations in Breast Cancer Cells
Current Cancer Drug Targets Role of ATP-Binding Cassette (ABC) Transporters in Interactions Between Natural Products and Drugs
Current Drug Metabolism Drug Resistance in Childhood Acute Myeloid Leukemia
Current Pharmaceutical Biotechnology Radio-localization of Non-Palpable Breast Lesions Under Ultrasonographic Guidance: Current Status and Future Perspectives
Current Radiopharmaceuticals Different Treatment Strategies for Pediatric Brain Tumors
Current Pediatric Reviews Targeting Cyclooxygenase-2 in Hematological Malignancies: Rationale and Promise
Current Pharmaceutical Design